Abstract:For infectious diseases, rapid and accurate identification of the pathogen is critical for effective management and treatment, but diagnosis remains challenging, particularly in resource-limited areas. Methods that accurately detect pathogen nucleic acids can provide robust, accurate, rapid, and ultrasensitive technologies for point-of-care diagnosis of pathogens, and thus yield information that is invaluable for disease management and treatment. Several technologies, mostly PCR-based, have been employed for pathogen detection; however, these require expensive reagents and equipment, and skilled personnel. CRISPR/Cas systems have been used for genome editing, based on their ability to accurately recognize and cleave specific DNA and RNA sequences. Moreover, following recognition of the target sequence, certain CRISPR/Cas systems including orthologues of Cas13, Cas12a, and Cas14 exhibit collateral nonspecific catalytic activities that can be employed for nucleic acid detection, for example by degradation of a labeled nucleic acid to produce a fluorescent signal. CRISPR/Cas systems are amenable to multiplexing, thereby enabling a single diagnostic test to identify multiple targets down to attomolar (10-18 mol/L) concentrations of target molecules. Developing devices that couple CRISPR/Cas with lateral flow systems may allow inexpensive, accurate, highly sensitive, in-field deployable diagnostics. These sensors have myriad applications, from human health to agriculture. In this review, we discuss the recent advances in the field of CRISPR-based biosensing technologies and highlight insights of their potential use in a myriad of applications.

Crispr-cas based biosensing: A fast-expanding molecular diagnostic tool

Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects

Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application

CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection

CRISPR-Cas assisted diagnostics: A broad application biosensing approach

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

CRISPR/Cas Biosensing Technology: From Lab Assays to Integrated Portable Devices towards Wearables

CRISPR Cas system: A strategic approach in detection of nucleic acids

CRISPR/Cas‐Powered Biosensing

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR-Cas target recognition for sensing viral and cancer biomarkers

Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies

CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis.

Application of CRISPR/Cas Technology in Biological Nano‐Analysis

CRISPR-Cas Systems: Programmable Nuclease Revolutionizing the Molecular Diagnosis

CRISPR/Cas Systems towards Next-Generation Biosensing

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease

Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets

Editorial: CRISPR-based biosensors